Fig. 3

(a) Risk of death from any cause in trials of patients with primary melanoma tumors of >2 mm thickness and randomized to narrow (1–2 cm) or wide (3–4 cm) margins for excision. (b) Risk of local recurrence in trials of patients with primary melanoma tumors of >2 mm thickness and randomized to narrow (1–2 cm) or wide (3–4 cm) margins for excision. (c) Risk of regional recurrence in trials of patients with primary melanoma tumors of >2 mm thickness and randomized to narrow (1–2 cm) or wide (3–4 cm) margins for excision. (d) Risk of nodal recurrence in trials of patients with primary melanoma tumors of >2 mm thickness and randomized to narrow (1–2 cm) or wide (3–4 cm) margins for excision. (e) Risk of distant metastases in trials of patients with primary melanoma tumors of >2 mm thickness and randomized to narrow (1–2 cm) or wide (3–4 cm) margins for excision